MiR-0766 induces p53 accumulation and G2/M arrest by directly targeting MDM4

被引:33
|
作者
Wang, Qingqing [1 ]
Selth, Luke A. [2 ,3 ]
Callen, David F. [1 ]
机构
[1] Univ Adelaide, Sch Med, Ctr Personalised Canc Med, Breast Canc Genet Grp, Adelaide, SA, Australia
[2] Univ Adelaide, Sch Med, Dame Roma Mitchell Canc Res Labs, Adelaide, SA, Australia
[3] Univ Adelaide, Discipline Med, Freemasons Fdn Ctr Mens Hlth, Adelaide, SA, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
MicroRNA; MDM4; p53; cancer; cell cycle; TUMOR-SUPPRESSOR P53; MUTANT P53; MICRORNA EXPRESSION; NEGATIVE REGULATION; POSITIVE FEEDBACK; GENE-EXPRESSION; MIR-34A; PROLIFERATION; ONCOPROTEIN; TRANSITION;
D O I
10.18632/oncotarget.15530
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p53, a transcription factor that participates in multiple cellular functions, is considered the most important tumor suppressor. Previous evidence suggests that post-transcriptional deregulation of p53 by microRNAs contributes to tumorigenesis, tumor progression and therapeutic resistance. In the present study, we found that the microRNA miR-766 was aberrantly expressed in breast cancer, and that overexpression of miR-766 caused accumulation of wild-type p53 protein in multiple cancer cell lines. Supporting its role in the p53 signalling pathway, miR-766 decreased cell proliferation and colony formation in several cancer cell lines, and cell cycle analyses revealed that miR-766 causes G2 arrest. At a mechanistic level, we demonstrate that miR-766 enhances p53 signalling by directly targeting MDM4, an oncogene and negative regulator of p53. Analysis of clinical genomic data from multiple cancer types supports the relevance of miR-766 in p53 signalling. Collectively, our study demonstrates that miR-766 can function as a novel tumor suppressor by enhancing p53 signalling.
引用
收藏
页码:29914 / 29924
页数:11
相关论文
共 50 条
  • [1] Targeting MDM4 in neuroblastoma to reactivate p53 signaling
    Woodfield, Sarah E.
    Patel, Roma H.
    Ibarra, Aryana M.
    Chen, Zhenghu
    Vasudevan, Sanjeev A.
    CANCER RESEARCH, 2018, 78 (19)
  • [2] Targeting MDM4 to reactivate p53 signaling in neuroblastoma
    Chen, Zhenghu
    Woodfield, Sarah E.
    Patel, Roma H.
    Ibarra, Aryana M.
    Vasudevan, Sanjeev A.
    CANCER RESEARCH, 2019, 79 (13)
  • [3] miR-661 downregulates both Mdm2 and Mdm4 to activate p53
    Hoffman, Y.
    Bublik, D. R.
    Pilpel, Y.
    Oren, M.
    CELL DEATH AND DIFFERENTIATION, 2014, 21 (02): : 302 - 309
  • [4] Targeting MDM4 in hepatocellular carcinoma to reactivate p53 signaling
    Woodfield, Sarah E.
    Shi, Yan
    Patel, Roma H.
    Chen, Zhenghu
    Ibarra, Aryana M.
    Vasudevan, Sanjeev A.
    CANCER RESEARCH, 2017, 77
  • [5] miR-661 downregulates both Mdm2 and Mdm4 to activate p53
    Y Hoffman
    D R Bublik
    Y Pilpel
    M Oren
    Cell Death & Differentiation, 2014, 21 : 302 - 309
  • [6] EGFR inhibition in glioblastoma cells induces G2/M arrest and is independent of p53
    Kapoor, Gurpreet S.
    Christie, Antoire
    O'Rourke, Donald M.
    CANCER BIOLOGY & THERAPY, 2007, 6 (04) : 571 - 579
  • [7] Targeting the MDM2/MDM4 Interaction Interface as a Promising Approach for p53 Reactivation Therapy
    Pellegrino, Marsha
    Mancini, Francesca
    Luca, Rossella
    Coletti, Alice
    Giacche, Nicola
    Manni, Isabella
    Arisi, Ivan
    Florenzano, Fulvio
    Teveroni, Emanuela
    Buttarelli, Marianna
    Fici, Laura
    Brandi, Rossella
    Bruno, Tiziana
    Fanciulli, Maurizio
    D'Onofrio, Mara
    Piaggio, Giulia
    Pellicciari, Roberto
    Pontecorvi, Alfredo
    Marine, Jean Christophe
    Macchiarulo, Antonio
    Moretti, Fabiola
    CANCER RESEARCH, 2015, 75 (21) : 4560 - 4572
  • [8] Girolline, an antitumor compound isolated from a sponge, induces G2/M cell cycle arrest and accumulation of polyubiquitinated p53
    Tsukamoto, S
    Yamashita, K
    Tane, K
    Kizu, R
    Ohta, T
    Matsunaga, S
    Fusetani, N
    Kawahara, H
    Yokosawa, H
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (05) : 699 - 701
  • [9] Mdm2 Splice isoforms regulate the p53/Mdm2/Mdm4 regulatory circuit via RING domain-mediated ubiquitination of p53 and Mdm4
    Fan, Chuandong
    Wang, Xinjiang
    CELL CYCLE, 2017, 16 (07) : 660 - 664
  • [10] MDM2 and MDM4: p53 regulators as targets in anticancer therapy
    Toledo, Franck
    Wahl, Geoffrey M.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (7-8): : 1476 - 1482